- Home
- UNCY vs IAE Comparison
UNCY vs IAE Comparison
Compare UNCY & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- IAE
- Stock Information
- Founded
- UNCY 2016
- IAE 2007
- Country
- UNCY United States
- IAE United States
- Employees
- UNCY N/A
- IAE N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- IAE Trusts Except Educational Religious and Charitable
- Sector
- UNCY Health Care
- IAE Finance
- Exchange
- UNCY Nasdaq
- IAE Nasdaq
- Market Cap
- UNCY 74.2M
- IAE 74.3M
- IPO Year
- UNCY 2021
- IAE N/A
- Fundamental
- Price
- UNCY $3.94
- IAE $7.29
- Analyst Decision
- UNCY Strong Buy
- IAE
- Analyst Count
- UNCY 5
- IAE 0
- Target Price
- UNCY $55.20
- IAE N/A
- AVG Volume (30 Days)
- UNCY 520.0K
- IAE 46.3K
- Earning Date
- UNCY 11-12-2025
- IAE 01-01-0001
- Dividend Yield
- UNCY N/A
- IAE 10.21%
- EPS Growth
- UNCY N/A
- IAE N/A
- EPS
- UNCY N/A
- IAE N/A
- Revenue
- UNCY N/A
- IAE N/A
- Revenue This Year
- UNCY N/A
- IAE N/A
- Revenue Next Year
- UNCY $4,481.14
- IAE N/A
- P/E Ratio
- UNCY N/A
- IAE N/A
- Revenue Growth
- UNCY N/A
- IAE N/A
- 52 Week Low
- UNCY $3.40
- IAE $5.31
- 52 Week High
- UNCY $11.00
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- UNCY 37.53
- IAE 62.59
- Support Level
- UNCY $4.23
- IAE $7.22
- Resistance Level
- UNCY $4.43
- IAE $7.25
- Average True Range (ATR)
- UNCY 0.19
- IAE 0.07
- MACD
- UNCY -0.01
- IAE 0.00
- Stochastic Oscillator
- UNCY 22.22
- IAE 81.86
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.